Barts Health

London EC1M 6BQ

1 studies enrolling now · 3 studies all time

What they study most

Hepatitis C, Chronic, MSA - Multiple System Atrophy, Staphylococcus Aureus Bacteremia, Symptomatic Neurogenic Orthostatic Hypotension

Studies at this site

• Staphylococcus Aureus Network Adaptive Platform Trial — Recruiting now
• Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy — Running, not enrolling
• Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients — Completed